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Transmission and pathogenicity 
of novel reassortants derived 
from Eurasian avian-like and 2009 
pandemic H1N1 influenza viruses in 
mice and guinea pigs
Weili Kong1,*, Qinfang Liu2,*, Yipeng Sun1, Yu Wang1, Huijie Gao1, Lirong Liu1, Zhihua Qin1, 
Qiming He1, Honglei Sun1, Juan Pu1, Dayan Wang3, Xin Guo1, Hanchun Yang1,  
Kin-Chow Chang4, Yuelong Shu3 & Jinhua Liu1
Given the present extensive co-circulation in pigs of Eurasian avian-like (EA) swine H1N1 and 2009 
pandemic (pdm/09) H1N1 viruses, reassortment between them is highly plausible but largely 
uncharacterized. Here, experimentally co-infected pigs with a representative EA virus and a pdm/09 
virus yielded 55 novel reassortant viruses that could be categorized into 17 genotypes from Gt1 to Gt17 
based on segment segregation. Majority of novel reassortants were isolated from the lower respiratory 
tract. Most of reassortant viruses were more pathogenic and contagious than the parental EA viruses 
in mice and guinea pigs. The most transmissible reassortant genotypes demonstrated in guinea pigs 
(Gt2, Gt3, Gt7, Gt10 and Gt13) were also the most lethal in mice. Notably, nearly all these highly virulent 
reassortants (all except Gt13) were characterized with possession of EA H1 and full complement of 
pdm/09 ribonucleoprotein genes. Compositionally, we demonstrated that EA H1-222G contributed to 
virulence by its ability to bind avian-type sialic acid receptors, and that pdm/09 RNP conferred the most 
robust polymerase activity to reassortants. The present study revealed high reassortment compatibility 
between EA and pdm/09 viruses in pigs, which could give rise to progeny reassortant viruses with 
enhanced virulence and transmissibility in mice and guinea pig models.
Influenza is one of the most important causes of respiratory tract infection that results in around 200,000–500,000 
deaths each year worldwide. In influenza pandemics, incidence and pneumonic manifestations are often much 
more frequent with ensuing surge in global mortality. Historically, pandemic influenza A viruses, such as from 
1957, 1968 and 2009, were all reassortants derived from human and animal influenza viruses1,2. Pigs are thought 
to be “mixing vessels” for influenza viruses and play a significant role in the generation of pandemic viruses by 
genetic reassortment owing to their permissiveness to both avian and human influenza viruses3. The most recent 
2009 H1N1 pandemic was caused by a novel reassortant swine H1N1 virus with genetic segments from Eurasian 
avian-like and North American swine influenza viruses (SIVs)2 which is a stark reminder of the need to continu-
ally monitor the evolving nature of influenza viruses in pigs in anticipation for the next pandemic.
Different lineages of influenza viruses, including Eurasian avian-like (EA) H1N1, triple reassortant (TR) 
H1N2, classical swine H1N1, 2009 pdm H1N1 and H3N2, are co-circulating in pig herds with some geographic 
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restrictions4–6. EA H1N1 virus first emerged in Europe in 1979 and has replaced the classical swine H1N1 virus 
which indicates that the EA virus has competitive advantage in pigs7–9. In 2007, EA virus was first reported in 
Hong Kong and eventually became dominant in China10,11. The EA virus has been documented to cause respira-
tory infection in humans12,13. Since the global human population is expected to have little to no immunity against 
EA virus or virus with EA HA gene14–17, the EA swine lineage of viruses could be a potential genetic source for the 
development of future pandemic strains.
The pdm/09 virus continues to circulate in humans and has effectively become a seasonal virus. Pigs are highly 
susceptible to pdm/09 virus, which repeatedly infected pigs around the world and reassortment with pdm/09 
virus has also occurred with many other SIV lineages apart from the EA lineage18,19. Previous studies have iden-
tified reassortant swine influenza virus derived from EA and pdm/09 lineages in Hong Kong, Germany, Italy 
and United Kingdom20–25. Recent surveys of SIVs from 2009–2012 in South China found marked changes in the 
evolutionary patterns and ecosystem of SIVs and that only the internal genes of the pdm/09 virus were present in 
dominant lineages in pigs10. Collectively, these observations suggest that reassortants between pdm/09 and EA 
H1N1 viruses could potentially generate reassortant viruses with novel antigenicity for humans. Although many 
reassortants between pdm/09-origin viruses and enzootic SIVs have been detected, no systematic study has been 
reported on reassortants between pdm/09 and EA viruses.
To better understand the genetic diversity and biological properties of novel reassortants between pdm/09 and 
EA influenza virus, we experimentally co-infected pigs with EA swine H1N1 and pdm/09 viruses, and examined 
the reassortant patterns of progeny viruses and their pathogenicity/transmissibility in mice and guinea pigs. We 
found that the two virus lineages could generate reassortant viruses with enhanced pathogenicity and transmis-
sibility in both animal models, and that the most pathogenic and transmissible reassortants retained the EA H1 
and full complement of pdm/09 RNP gene segments.
Results
Reassortants from co-infection of pigs with parental EA/FJ04 and pdm/BJ09 H1N1 viruses. To 
systematically examine reassortants obtained from co-infection of swine with EA and pdm/09 viruses, a rep-
resentative EA virus A/Swine/Fujian/204/2007 (EA/FJ04) and a representative pdm/09 virus A/Beijing/7/2009 
(pdm/BJ09) were selected for coinfection of six pigs inoculated by intranasal and intratracheal routes. At 3 days 
post-infection (dpi), all pigs exhibited clinical symptoms including coughing and pyrexia. Daily nasal washes 
from 1 to 5 dpi, and bronchoalveolar fluids (BALFs) from 3 euthanatized pigs each time at 3 and 5 dpi were 
collected. Ten plaque purified viruses were isolated and sequenced from each nasal wash and BALF sample. A 
total of 300 purified viruses (about 50 per pig) were isolated, of which 240 viruses were from nasal washes and 
60 viruses were from BALFs. Based on the parental origin of eight gene segments, plaque-purified viruses were 
classified as EA/FJ04 or pdm/BJ09 genotype if they contained all eight genes from only one parental virus, and as 
reassortants if they contained segments of both parental viruses.
Pdm/BJ09 virus was most frequently isolated from all six pigs (221/240 from nasal passage and 24/60 from low 
respiratory tract, LRT). In contrast, EA/FJ04 virus was not found in any of the samples. A total of 55 reassortants 
identified from the 300 virus clones (55/300, 18%). Sixty percent (33/55) of all reassortant viruses possessed the 
EA/FJ04 H1 gene, which in turn could be assigned into 10 distinct genotypes, Gt1 to Gt10, based on segment 
segregation patterns (Table 1). The remaining 40% (22/55) of reassortants housed the pdm/BJ09 H1 gene, which 
could be designated into 7 distinct genotypes: Gt11 to Gt17 (Table 1). Gt2, mainly found in BALFs, was the 
most common genotype constituting more than 25% of all reassortants (14/55) where the H1 and NS segments 
were from the parental EA/FJ04 virus with the remaining 6 gene segments from the pdm/BJ09 virus (Table 1). 
Reassortants Gt13 at 13% (7/55) and Gt14 also at 13% (7/55) were the dominant pdm/BJ09 H1 genotypes isolated 
only from the nasal passage.
Remarkably, all 55 reassortant viruses carried the PB2, PA, and NP from pdm/BJ09 virus. On the other hand, 
the NS and HA genes of EA/FJ04 virus were highly represented in the reassortants at 65% (36/55) and 60% 
(33/55) respectively. The EA/FJ04 virus PB1, NA, M gene segments were found in only 25%, 35% and 18% of all 
reassortants respectively. In summary, the most frequent reassortant genotypes, based on H1 parental EA/FJ04 
classification of Gt1 to Gt10 or H1 pdm/BJ09 of Gt11 to Gt17, were Gt2 (25%), Gt13 (13%), Gt14 (13%) and Gt7 
(5/55, 9%). The four genotypes all contained RNP and M gene segments derived from the pdm/BJ09 virus which 
suggest that these internal genes have competitive advantage in replication over corresponding EA/FJ04 genes 
(Table 1).
Distribution of reassortant viruses in respiratory tracts of co-infected pigs. There is clear dif-
ferential expression of avian-like sialic acid α 2,3-galactose (SAα 2,3-Gal) linked and human-like sialic acid α 
2,6-galactose (SAα 2,6-Gal) linked receptors along the porcine respiratory tract, with SAα 2,3-Gal linked receptors 
mainly found in the LRT26. We found that the frequency of reassortment was low in nasal passage throughout the 
infection period, but progressively increased during infection in lungs (Fig. S1). Thirty-six out of 60 (60%) viruses 
isolated from BALFs and 19 out of 240 (8%) from nasal washes were reassortant viruses. The 19 reassortants iso-
lated from the nasal passage comprised five genotypes of Gt7, Gt10, Gt13, Gt14, and Gt15 (Table 1). Eighty four 
percent (16/19) of nasal passage-derived reassortants comprised H1 of parental pdm/BJ09 virus. Only 3 of the 
19 reassortant viruses, one Gt7 and two Gt10 viruses carried the H1 of EA/FJ04 virus. The 36 reassortant viruses 
isolated from the LRT comprised 13 different genotypes excluding Gt10, Gt13, Gt14 and Gt15. Seventy eight per-
cent (28/36) of these reassortants carried the EA/FJ04 H1 gene. Of note, Gt7 was found in both upper and LRT. 
In summary, majority of the reassortants harboring the H1 from the EA/FJ04 virus were observed in the LRT of 
infected pigs, coincident with the presence of avian-like sialic acid receptors26.
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Transmissibility of EA/FJ04 and pdm/BJ09 reassortants in guinea pigs. Guinea pigs were used to 
determine the transmissibility of reassortant viruses. As shown in Fig. 1, both parental EA/FJ04 and pdm/BJ09 
viruses readily infected guinea pigs. Pdm/BJ09 virus replicated more efficiently in the nasal passage than EA/FJ04 
virus and was detected in the nasal washes of all three inoculated and three in-contact guinea pigs, which indi-
cated efficient horizontal transmission. However, there was no transmission of EA/FJ04 virus to in-contact guinea 
pigs. Based on virus transmissibility, the 17 reassortant genotypes were categorized into three groups:
1.    Transmissibility group I comprised 6 reassortant genotypes, Gt2, Gt3, Gt7, Gt10, Gt13 and Gt14, with high 
transmissibility that was similar to that of the parental pdm/BJ09 virus (Fig. 1). The six genotypes made up 
67% (37/55) of all reassortant isolates. Most of the reassortants of Gt2, Gt3, Gt7, and Gt10 in this group har-
bored EA/FJ04 H1 gene. Notably, all viruses from this group contained PB2, PB1, PA and NP segments of the 
pdm/BJ09 virus.
2.   Transmissibility group II composed of 8 reassortant genotypes, Gt1, Gt4, Gt6, Gt9, Gt12, Gt15, Gt16 and 
Gt17, that showed reduced transmissibility but still higher than the parental EA/FJ04 virus. Gt1, Gt4, Gt6, 
Gt12, Gt15 and Gt17 reassortants were transmitted to two out of the three in-contact guinea pigs, while Gt9 
and Gt16 reassortants infected one out of three in-contact animals (Fig. 2). The 8 genotypes comprised 20% 
(11/55) of reassortant viruses. Interestingly, all viruses in this group except Gt1 contained PB2, PA and NP 
gene segments of the pdm/BJ09 virus and PB1 segment of the EA/FJ04 virus.
3.   Transmissibility group III comprised 3 reassortant genotypes, Gt5, Gt8 and Gt11, which showed no horizontal 
transmission which was similar to that of the parental EA/FJ04 virus. These viruses were only detected in the 
nasal washes of all three inoculated guinea pigs (Fig. S2). The two genotypes (Gt8, Gt11) harbored PB2, PA 
and NP gene segments of the pdm/BJ09 virus and PB1 segment of the EA/FJ04 virus.
Seroconversion occurred in all inoculated animals and in infected in-contact animals. For statistical analyses, the 
area under the nasal wash curve between 2 and 6 dpi (AUC2–6 dpi), which measured duration of peak virus 
shedding, was calculated for each guinea pig, as previously described27. The AUC2–6 dpi value of the EA/FJ04 virus 
group was significantly lower than that of the pdm/BJ09 virus group and all other reassortant genotypes (Fig. S3). 
These results suggested that in guinea pigs pdm/BJ09 genes enhanced replication of reassortant viruses.
Pathogenicity of EA/FJ04 and pdm/BJ09 reassortants in mice. All reassortant genotypes and the 
two parental EA/FJ04 and pdm/BJ09 viruses were assessed for pathogenicity in BALB/c mice. Both parental 
viruses readily infected mice, and LD50 of EA/FJ04 and pdm/BJ09 was > 105.5 and 104.5 TCID50 respectively. Pdm/
BJ09 virus replicated more efficiently in the LRT than EA/FJ04 virus on day 4 following intranasal virus inocula-
tion at 105 TCID50. Mice that lost more than 25% of their body weight were euthanized. Pdm/BJ09 virus caused 
> 25% weight loss which ensured complete mortality in mice whereas EA/FJ04 virus caused only 1% weight 
loss with no mortality. All tested reassortants readily infected mice and replicated in the LRT (Table 2). The 
Virus Segments
Lunga N.S.b PercentagePB2 PB1 PA HA NP NA M NS
Gt1 P P P E P P E P 1/60 0/240 1/300 (0.3%)
Gt2 P P P E P P P E 14/60 0/240 14/300 (4.7%)
Gt3 P P P E P E E E 1/60 0/240 1/300 (0.3%)
Gt4 P E P E P E P E 2/60 0/240 2/300 (0.7%)
Gt5 P P P E P E P P 1/60 0/240 1/300 (0.3%)
Gt6 P E P E P P P E 2/60 0/240 2/300 (0.7%)
Gt7 P P P E P P P P 4/60 1/240 5/300 (1.7%)
Gt8 P E P E P P E E 2/60 0/240 2/300 (0.7%)
Gt9 P E P E P E E P 3/60 0/240 3/300 (1.0%)
Gt10 P P P E P E P E 0/60 2/240 2/300 (0.7%)
Gt11 P E P P P P P E 2/60 0/240 2/300 (0.7%)
Gt12 P E P P P E P E 1/60 0/240 1/300 (0.3%)
Gt13 P P P P P P P E 0/60 7/240 7/300 (2.3%)
Gt14 P P P P P E P P 0/60 7/240 7/300 (2.3%)
Gt15 P E P P P P P P 0/60 2/240 2/300 (0.7%)
Gt16 P E P P P P E E 1/60 0/240 1/300 (0.3%)
Gt17 P E P P P E E E 2/60 0/240 2/300 (0.7%)
pdm/BJ09 P P P P P P P P 24/60 221/240 245/300 (83%)
EA/FJ04 E E E E E E E E 0/60 0/240 0/300 (0%)
Table 1.  Genotypes and distribution of reassortants recovered from coinfected pigs. The virus segments 
derived from the pdm/BJ09 are denoted P, and those derived from EA/FJ04 virus are denoted E. aNo. of 
reassortant isolates/total no. of viruses examined in BALF. bNo. of reassortant isolates/total no. of viruses 
examined in nasal swab specimen, N.S. nasal swab.
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reassortant genotypes were additionally categorized into three groups according to their relative pathogenicity in 
mice compared with parental viruses:
1.   Pathogenicity group I comprised 6 reassortant genotypes, Gt2, Gt3, Gt5, Gt7, Gt10 and Gt13, with pathogenic-
ity higher than either parental virus (Table 2). With LD50 at103.5 to103.8 TCID50 and mean survival time (MST) 
of 4 to 5.3 days, they constituted 58% (32/55) of reassortant viruses. Infected mice displayed obvious clinical 
signs of huddling, ruffled fur, severe dyspnea by 4 dpi and complete mortality after 5 days. With this group 
of reassortants, even at a reduced infection dose of 104 TCID50, severe clinical signs were evident (data not 
shown). Hematoxylin and eosin (H&E) lung histopathology performed on three mice from each genotype at 4 
dpi revealed severe bronchopneumonia and interstitial pneumonia, characterized by edema, epithelial erosion 
and massive infiltration of inflammatory monocytic cells (Fig. 3A,B).
Figure 1. Replication and transmission of reassortants Gt2, 3, 7, 10, 13 and 14 (transmission group I) and 
parental pdm/BJ09 and EA/FJ04 viruses in guinea pigs. Each group of three guinea pigs (grey columns) was 
intranasally (i.n.) inoculated with 105TCID50 of each virus; 24 hours later, three in-contact guinea pigs (colorful 
columns) were placed with each infected group. Nasal washes were collected every two days from all animals. 
Each bar represents the virus titer from nasal wash of an individual animal. The dashed blue lines indicate the 
lower limit of detection.
www.nature.com/scientificreports/
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2.   Pathogenicity group II composed of 8 reassortant genotypes, Gt4, Gt6, Gt8, Gt11, Gt14, Gt15, Gt16 and Gt17, 
that showed pathogenicity similar to that of the pdm/BJ09 virus. With LD50 at 104.3 to 104.5 TCID50 and MST 
between 4.3–8.3 days, this group of reassortants constituted 36% (20/55) of all reassortant isolates. Infected 
mice, as in pathogenicity group I, showed severe clinical signs, bronchopneumonia and eventual deaths simi-
lar to those caused by the parental pdm/BJ09 virus (Fig. 3C,D). However, this group of reassortants at a lower 
inoculation dose of 104TCID50 elicited no clinical signs in mice (data not shown).
3.   Pathogenicity group III comprised 3 reassortant genotypes, Gt1, Gt9 and Gt12, which showed reduced vir-
ulence similar to that of the EA/FJ04 virus. This group did not cause any death over 2 weeks of infection and 
constituted only 5% (3/55) of total reassortant viruses. Clinical signs from infected mice were not apparent 
and lung histopathological changes were mild to moderate (Fig. 3E,F). Notably, EA/FJ04 virus grew to lower 
virus titers in lungs at 4 dpi than all reassortants, which suggested that introduction of pdm/BJ09 genes into 
EA/FJ04 virus enhanced viral replication in mice (Table 2).
Figure 2. Replication and transmission of reassortants (Gt1, 4, 6, 9, 12, 15, 16 and 17) of higher 
transmissibility (transmission group II) than the parent EA/FJ04 virus in guinea pigs. Each group of three 
guinea pigs (grey columns) was i.n. inoculated with 105TCID50 of each virus; 24 hours later, three in-contact 
guinea pigs (colorful columns) were placed with each group. Nasal washes were collected every two days from 
all animals. Each bar represents the virus titer from nasal wash of an individual animal. The dashed blue lines 
indicate the lower limit of detection.
www.nature.com/scientificreports/
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In summary, five out of six reassortant genotypes in the most pathogenic category (Gt2, Gt3, Gt5, Gt7 and 
Gt10 in pathogenicity group I) housed the H1 gene from the EA/FJ04 virus; in particular Gt7 reassortant viruses 
only contained H1 gene from EA/FJ04, indicating that EA H1 contributed to virulence in these reassortants. All 
six genotypes in this high pathogenicity group housed the 4 RNP genes of PB1, PB2, PA and NP from the pdm/
BJ09 virus, suggesting that pdm/BJ09 RNP is critical to enhanced pathogenicity. Notably, highly pathogenic Gt2, 
Gt3, Gt7, Gt10 and Gt13 reassortants were earlier found to be highly transmissible in guinea pigs (Fig. 1).
HA-222G was critical in the pathogenicity of EA H1 reassortant virus in mice. Our above results 
suggested that the EA/FJ04 HA gene is an important virulence factor in the reassortant viruses. Receptor-binding 
specificity of HA is an important molecular determinant of host range, transmissibility and replication28. To 
ascertain the receptor-binding properties of the two parental viruses, we performed binding of EA/FJ04 and pdm/
BJ09 viruses to a glycan array panel of SAα 2,3- or SAα 2,6-linked sialosides (Fig. 4). In keeping with the previous 
reports29, our results showed that pdm/BJ09 virus bound to SAα 2,6 Gal linked receptor only. However, EA/FJ04 
virus additionally exhibited SAα 2,3 Gal linked receptor binding.
Previous studies showed that HA D222G mutation in 2009 pdm virus resulted in additional SAα 2,3 linked 
receptor binding preference and enhanced virulence in mice and macaques30,31. EA/FJ04 virus also contains G222 
in its HA protein. To determine whether residue G222 in EA HA plays a role in pathogenicity, we generated a 
reassortant rgEAH1/pdm virus that comprised H1 gene from EA/FJ04 virus and all other genes from pdm/
BJ09 virus, which had the same genotype as Gt7 and showed binding affinity for SAα 2,6 and SAα 2,3 Gal linked 
receptors. Additionally, we introduced a HA-G222E mutation into the EA H1 gene of rgEAH1/pdm to generate 
a further reassortant (rgEAH1-G222E/pdm). We found that HA G222E mutation introduced into rgEAH1/pdm 
virus abolished binding affinity for SAα 2,3 Gal linked receptor (Fig. 4). We further determined that rgEAH1/
pdm virus caused 100% mortality in mice at challenge doses of 104 TCID50 and105 TCID50 (Fig. S4); however, 
rgEAH1-G222E/pdm mutant only caused slight weight loss and no mortality at the 104 TCID50 challenge doses. 
Therefore, our results demonstrated that not only EA H1 gene but also HA 222G from parental EA/FJ04 virus 
contributed to the virulence of EA H1 reassortant virus by conferring, at least in part, affinity for the avian SAα 
2,3-Gal linked receptor which is mainly localized in the porcine LRT26. However, HA222G did not enhance the 
virulence of wild type EA/FJ04 in mice, suggesting that combination of HA222G with genes from pdm/BJ09 was 
responsible for viral virulence in mice.
RNP of pdm/BJ09 virus conferred robust polymerase activity to reassortant viruses. In the 
55 reassortants, only two RNP gene combinations were found, one parental pdm/BJ09 RNP complex from the 
pdm/BJ09 virus and one hybrid RNP complex of PB2, PA and NP from the pdm/BJ09 virus and PB1 from EA/
Genotypea
Virus Segments
LD50 (Log10pfu) MSTb (Days) Viral titerc (TCID50/mL) NaturedPB2 PB1 PA HA NP NA M NS
Pathogenicity group III
Gt1 P P P E P P E P ≥ 5.5 ≥ 14 5.3 ± 0.4
Gt9 P E P E P E E P ≥ 5.5 ≥ 14 5.5 ± 0.1
Gt12 P E P P P E P E ≥ 5.5 ≥ 14 5.4 ± 0.1
EA/FJ04 E E E E E E E E ≥ 5.5 ≥ 14 3.8 ± 0.4
Pathogenicity group II
pdm/BJ09 P P P P P P P P 4.5 4.3 4.9 ± 0.5
Gt4 P E P E P E P E 4.5 4.3 6.1 ± 0.3 F10
Gt6 P E P E P P P E 4.3 4 5.8 ± 0.6
Gt8 P E P E P P E E 4.3 4 5.3 ± 0.4
Gt11 P E P P P P P E 4.5 4.7 5.8 ± 0.4
Gt14 P P P P P E P P 4.3 4.7 5.3 ± 0.1 F20,23
Gt15 P E P P P P P P 4.5 8.3 5.3 ± 0.4
Gt16 P E P P P P E E 4.5 6.3 5.7 ± 1.1
Gt17 P E P P P E E E 4.5 4.7 6.4 ± 0.1
Pathogenicity group I
Gt2 P P P E P P P E 3.8 4.7 5.7 ± 0.1
Gt3 P P P E P E E E 3.8 4.7 5.3 ± 0.1
Gt5 P P P E P E P P 3.8 4.3 5.7 ± 0.1 F10,22,23
Gt7 P P P E P P P P 3.5 4.7 6 ± 0.7
Gt10 P P P E P E P E 3.5 5.3 5.1 ± 0.3
Gt13 P P P P P P P E 3.5 4 4.9 ± 0.5
Table 2.  Pathogenicity of reassortant viruses in mice compared with parental EA/FJ04 and pdm/
BJ09 viruses. aPathogenicity group I: reassortants with higher pathogenicity than both parental viruses; 
Pathogenicity group II: reassortants with pathogenicity similar to that of the pdm/BJ09 virus; Pathogenicity 
group III: reassortants with pathogenicity similar to or lower than that of the EA/FJ04 virus. The virus segments 
derived from the pdm/BJ09 are denoted P, and those derived from EA/FJ04 virus are denoted E. bMST, mean 
survival time of mice infected with 105TCID50. cVirus titers in lung are means ± SDs of the log10 TCID50/mL at 
4 dpi of three mice infected with 105TCID50. dIf reassortant virus was isolated from pigs in field, it is noted as F. 
References were added.
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FJ04 virus, with a proportion of 69% (38/55) to 31% (17/55) respectively (Pearson’s χ 2, p < 0.001). All reassortant 
viruses from pathogenicity group I and transmissibility group I housed the pdm/BJ09 virus RNP complex. Given 
that RNP activity correlates with replication and pathogenicity32,33, the polymerase activity of different RNP com-
binations between pdm/BJ09 and EA/FJ04 was evaluated by minigenome assays. Homologous parental pdm/BJ09 
virus RNP complex showed significantly higher activity than that of homologous parental EA/FJ04 virus in 293T 
cells (Fig. 5). RNP activities of hybrid RNP complexes, however, varied substantially. All hybrid RNPs exhibited 
polymerase activities that were much less than the pdm/BJ09 virus RNP and more similar to the EA/FJ04 virus 
RNP complex. Therefore, we suggest that the selectivity for homologous RNP complex of pdm/BJ09 virus in 
reassortant viruses was likely due to its relatively high polymerase activity.
To evaluate the role of pdm/RNP in the pathogenicity of reassortants, a pdmRNP/EAH1N1 virus containing 
RNP genes from pdm/BJ09 virus and the remaining four genes from EA/FJ04 virus was generated and tested 
in mice. We found that the pdm/RNP genes significantly enhanced virus pathogenicity of pdmRNP/EAH1N1 
in mice compared with the parental EA/FJ04 virus (Fig. S5), which suggests that pdm/RNP contributed to the 
virulence of reassortant virus in mice.
Low antigenic cross-reactivity of EA SIV with human influenza vaccine strains. H1N1/
pdm09-like and H3N2 antigenic components are presently incorporated in human seasonal vaccines. To 
assess cross-protection of such seasonal influenza vaccines against EA viruses, we performed hemagglutina-
tion inhibition (HI) assays with a panel of different sera (Table S1). The results showed that EA H1N1 viruses 
(Shangdong/07/2011 and Fujian/04/2007) reacted well with homologous virus sera with HI titer of 1:1280; 
Figure 3. Reassortants (Gt7, 12, 13 and 17) of EA/FJ04 and pdm/BJ09 viruses exhibited a spectrum of lung 
histopathology at 4 days post infection. (A) Gt7 and (B) Gt13 viruses caused severe bronchopneumonia and 
interstitial pneumonia with erosion of epithelial lining (open arrow), widespread infiltrate of monocytic cells 
(triangle) and interstitial edema around blood vessels (solid arrow). (C) Parental pdm/BJ09 and (D) Gt17 virus 
infection resulted in less severe bronchopneumonia with edema, erosion of epithelial lining (open arrow) and 
some infiltration of monocytic cells (triangle) around blood vessels (solid arrow). (E) Parental EA/FJ04 and  
(F) Gt12 viral infections were least severe with reduced erosion of epithelial cells (open arrow) and few monocytic 
inflammatory cells (triangle) around blood vessels (solid arrow). Lung sections were stained with hematoxylin and 
eosin. Scale bar = 100 μ m.
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however, they showed no reactivity with sera against human seasonal H1N1 (A/Tianjin-jinnan/15/2009, not 
H1N1/pdm09-like) and pdm/09 H1N1 viruses. This suggests that neither seasonal H1N1 nor pdm/09 H1N1 
vaccine can currently provide effective humoral protection against EA/FJ04. Likewise, sera against the EA H1N1 
viruses showed little cross-reactivity with pdm/09 H1N1 viruses of A/California/07/2009 and A/Beijing/7/2009, 
implying that EA H1N1 vaccine may in turn offer little protection to pdm/09 H1N1 virus infection. Notably, low 
cross-reactive HI antibodies against EA/FJ04 were observed in sera collected from children vaccinated by bivalent 
vaccine of H3N2 and H1N1 viruses, which is in accordance to previous studies16,17,25. Collectively, these results 
showed that EA H1N1 and pdm/09 H1N1, seasonal H1N1 and H3N2 viruses are antigenically distinct.
Discussion
Eurasian avian-like swine H1N1 viruses and 2009 pandemic H1N1 viruses are prevalent in pigs in Eurasia7,20,21. 
Co-infection with two different influenza viruses in a host can mathematically produce up to 256 different 
Figure 4. Relative viral affinity for α-2,6-linked and α-2,3-linked sialic acids. Parental pdm/BJ09, parental 
EA/FJ04, rgEAH1/pdm and rgEAH1-G222E/pdm were subjected to direct binding to sialylglycopolymers 
containing either α -2,3-linked (blue) or α -2,6-linked (red) sialic acids.
Figure 5. Polymerase activity of 16 RNP combinations between the EA/FJ04 and pdm/BJ09 viruses. 293T 
cells were transfected in duplicate with luciferase reporter plasmid p-Luci and internal control plasmid Renilla, 
together with different combinations of PB2, PB1, PA and NP plasmids from EA/FJ04 and pdm/BJ09 viruses. 
Viral segments derived from the pdm/BJ09 virus are in red, and those derived from EA/FJ04 viruses are in blue.
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reassortant viruses. In our co-infection of pigs with EA/FJ04 and pdm/BJ09 viruses, 55 out of 300 isolated virus 
clones were reassortants. We found that majority of the reassortant viruses (65%, 36/55) were generated from the 
LRT. Seventy eight % of LRT reassortants (28/36) carried the H1 HA gene from the parental EA/FJ04 virus. The 
5 highly infectious reassortants genotypes of Gt2, Gt3, Gt7, Gt10 and Gt13 in guinea pigs were also amongst the 
most pathogenic in mice. These 5 genotypes all harbored the pdm/BJ09 RNP gene segments (PB1, PB2, PA and 
NP). We further demonstrated that pdm/09-RNP and EA-H1HA contributed to enhanced virulence and trans-
missibility in the reassortant viruses. No progeny EA/FJ04 virus was isolated which suggests that the competing 
pdm/BJ09 virus was much more competent at replication than EA/FJ04 virus. The present findings revealed high 
reassortment compatibility between EA and pdm/09 viruses in pigs, which could generate novel progeny viruses 
with enhanced virulence and transmissibility in mice and guinea pigs. A H3N2 variant derived from endemic 
H3N2 TR virus and pdm/09-origin virus in pigs has caused more than 340 human infection cases in the USA 
since 2011, which emphasized the role of pdm/09-origin internal gene in the genesis of influenza reassortants 
with the potential to infect humans34.
Pigs are commonly considered as “mixing vessels” for the reassortment of influenza viruses; however, how 
and where reassortment occurs in the pig remains unclear. Reassortment is likely to be influenced by infectious 
dose, cell tropism, host species and pre-existing immunity35. Ma et al. intratracheally co-infected pigs with an EA 
H1N1 virus and North American triple reassortant H1N1 virus. They found that reassortment mainly occurred 
in the lung of co-infected pigs36. In our study, we inoculated equal virus doses intranasally and intratracheally. 
Eight percent (19/240) of the isolated virus clones from the nasal passage and 60% (36/60) from the LRT were 
reassortants, indicating that most reassortants were isolated in the LRT.
In this study, the Gt7 reassortant viruses only containing H1 gene from EA/FJ04 showed increased patho-
genicity in mice relative to either parental virus, which indicated that the EA H1 gene could be responsible for 
enhanced virulence in mice. Amino acid at G222 of pdm/09 HA was reported to be associated with severe dis-
ease and fatality in human patients37,38. HA- G222 variants have dual receptor specificity for SAα 2,3-Gal linked 
and SAα 2,6-Gal linked receptors, which confer expanded tissue tropism leading to increased pathogenicity in 
mice and ferrets31,39. We showed that a HA-G222E mutation in the EAH1/pdm reassortant resulted in significant 
reduction in pathogenicity in mice and eliminated its binding to SAα 2,3-Gal linked receptors. However, the 
HA222G isoform in parental EA/FJ04 virus did not confer elevated virulence in mice, which suggested that addi-
tional contextual genes in the reassortant virus are necessary for pathogenicity. The ability of EA-H1 reassortants 
to bind avian SAα 2,3-Gal linked receptors is expected to enhance their propagation in the porcine and human 
LRT where avian receptors-like are present26,40.
The other major virulence factor identified in the reassortants from co-infection with EA/FJ04 and pdm/BJ09 
viruses is the dominance of the pdm/09 RNP complex. Polymerase activity of the pdm/09 RNP complex was sig-
nificantly higher than those of parental EA and reassortant viruses. Collectively, the EA-H1 gene and members of 
pdm/09-RNP complex are major contributors to the virulence and transmissibility of EA H1 reassortants. Since 
recent surveillance data indicated that the internal genes of pdm/09 are widely established in pig populations in 
China10, emergence of novel reassortant viruses comprising EA-HA and pdm/09 RNP genes could pose potential 
threat to public health.
EA viruses have been circulating in pig populations for over 30 years. There have been occasional human 
cases of infection but no persistent human transmission has been documented13,41. Hence, there is little specific 
immunity against EA H1N1 viruses in the human population. Although, cross-reactive antibodies against EA 
H1N1 were found in a small proportion of human population, most do not have such antibodies16,17,25. We found 
that current seasonal H1N1 and H3N2 influenza vaccines do not appear to confer cross-reactive humoral pro-
tection against EA viruses. Therefore, there is a need of a novel EA H1N1 vaccine in anticipation of its possible 
emergence.
In summary, our data highlight the potential public health danger of novel viruses arising from reassortment 
in pigs between circulating EA swine H1N1 and pdm/09 H1N1 viruses. Such reassortants for which there is little 
apparent cross protection from current vaccines could be much more pathogenic and transmissible than parental 
viruses.
Materials and Methods
Ethics statement. All animal studies were performed in strict accordance with the recommenda-
tions in the Guide for the Care and Use of Laboratory Animals of China Agricultural University (CAU) (ID: 
SKLAB-B-2010-003) and all animal research was approved by the Beijing Association for Science and Technology 
of China (approval ID SYXK, Beijing, 2007–0023). Ten-day-old specific pathogen-free (SPF) chicken embryos 
were obtained from Merial (Beijing, China).
Viruses and cells. Two Eurasian avian-like swine influenza viruses including A/Swine/FuJian/04/2007 
(EA/FJ04, H1N1) and A/Swine/Shandong/07/2011 (H1N1), and 2009 human pandemic H1N1 viruses, A/
Beijing/7/2009 (pdm/BJ09) were isolated and kept in our laboratory42,43. All viruses were grown in SPF chicken 
embryos. Madin-Darby canine kidney (ATCC, USA) and 293T (ATCC, USA) cells were cultured in high glucose 
Dulbecco’s modified Eagle medium (DMEM) supplemented with antibiotics (100 U/ml penicillin and 100 μ g/ml 
streptomycin) and 10% fetal bovine serum (Invitrogen) at 37 °C with 5% CO2.
Co-infection of pigs and samples collection. Four to 5 weeks old Landrace-Large White cross pigs were 
sourced from a high health status farm. All animals were sero-negative for circulating influenza viruses (H1N1, 
H3N2, H5N1 and H9N2) by Hemagglutination inhibition (HI) assay. Six pigs were inoculated intranasally and 
equally intratracheally with 106.0 TCID50 of EA/FJ04 and pdm/BJ09 in 3 ml phosphate buffered saline (1.5mL 
for each challenge route). All inoculated pigs were observed twice daily for clinical signs until the end of the 
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experiment. Nasal washes were collected from all pigs every 24 h for 5 days post infection (dpi). Three pigs were 
euthanized at 3 and 5 dpi. The lungs were flushed with 50 ml fresh DMEM to obtain bronchoalveolar fluid (BALF) 
from each euthanized pig.
Virus plaque purification and identification of the genetic component. Each BALF sample and 
nasal wash from co-infected pigs was serially diluted tenfold and inoculated onto a monolayer of MDCK cells 
grown in six-well plates. Single plaques were randomly selected (approx. 10 plaques per sample) and plaque puri-
fication was performed three rounds in order to purify the virus. Viral RNA was extracted from purified virus by 
using the QIAamp Viral RNA Minikit (Qiagen), and RT-PCR was performed to amplify the segments of influenza 
A virus as described previously44. Full genomic DNA was sequenced by Tingske Biological Technology Co. Ltd 
(Beijing, China). To identify the reassortant patterns of progeny virus, all sequence results were analyzed by using 
DNA star software (Lasergene 7.1).
Receptor binding assays. Receptor binding specificity was analyzed by a solid-phase direct binding assay 
of biotinylated sialylglycopolymers as previously described29. Sodium salts of sialylglycopolymers poly-l-glutamic 
acid backbones containing N-acetylneuraminic acid linked to galactose through either an α -2,3 [Neu5Acα 
2,3Galβ 1,4GlcNAcβ 1-pAP] or an α -2,6 [Neu5Acα 2,6Galβ 1,4GlcNAcβ 1-pAP] were kindly provided by the 
Glycotech, Gaithersburg, MD
Ribonucleoprotein (RNP) minigenome luciferase assay. RNP genes (PB2, PB1, PA and NP) from 
EA/FJ04 and pdm/BJ09 viruses were cloned into pcDNA3.1 expressing vector. Polymerase activity of RNP from 
different gene combination of EA/FJ04 and pdm/BJ09 viruses was assayed in 293T cells as previously described45. 
Renilla luciferase plasmid pRL-TK (Promega) was also co-transfected to normalize the transfection efficiency. 
Firefly luciferase expression was normalized to Renilla luciferase expression (relative activity). The relative activ-
ity of the EA/FJ04 RNP was set as 100%, and the relative activities of the other reassortant RNP were presented 
relative to that.
Reverse genetics. All segments of EA/FJ04 and pdm/BJ09 were cloned into dual-promoter plasmid 
PHW2000 as described previously29; all plasmids were verified by sequencing to preclude any mutations. A pdm-
RNP/EAH1N1 reassortant virus containing RNP of pdm/BJ09 and other four genes from EA/FJ04 was gener-
ated by co-transfecting 293T cells with plasmids of PHW2000-EA/FJ04-HA, NA, M, NS and PHW2000-pdm/
BJ09-PB2, PB1, PA, NP. Similarly, a reassortant virus rgEAH1/pdm with HA gene from EA/FJ04 and the other 
seven genes from pdm/BJ09 was generated. To generate rgEAH1-G222E/pdm virus that contains a G to E substi-
tution at residue 222 of HA, HA-G222E was introduced into PHW2000-EA/FJ04-HA by site-directed mutagene-
sis kit (Qiagen). All viruses were propagated in MDCK cells and sequence verified prior to animal studies.
Mouse experiments. To evaluate the virulence of all reassortant viruses, groups of nineteen 5-week-old 
female BALB/c mice were intranasally inoculated with 50 μ L of 10-fold serial dilutions of each virus in PBS. Three 
mice infected with 105 TCID50 virus from each group were euthanized at 4 dpi and lung tissues were harvested for 
virus titration and hematoxylin and eosin staining. Body weights of all mice were monitored daily for 14 dpi, and 
mice that lost more than 25% of their body weight were euthanized on humane ground. LD50 were calculated and 
expressed as the TCID50 value corresponding to 1 LD50.
In order to examine the roles of EA/FJ04 H1-222G and pdm/BJ09 RNP genes in the pathogenicity of reassor-
tant viruses, groups of six mice were intranasally inoculated with rgEAH1-G222E/pdm, rgEAH1/pdm, pdmRNP/
EAH1N1 and EA/FJ04 at two infection doses of 104 and 105 TCID50, weight loss and survival rate were monitored 
daily until the end of this study (14dpi).
Guinea pig experiment. Female SPF/VAF guinea pigs (Hartley strain, 300–350 g, Vital River Laboratory 
Animal Technology), serum-negative for influenza virus, were used in these studies. Animals were anesthe-
tized by muscular injection with zoletil 100 (tiletamine-zolazepam; Virbac S.A., Garros, France) (10–15 mg/
kg). Groups of three animals were intranasally inoculated with 105 TCID50 of test viruses and housed in a 
cage per group. At 24 h post infection, three naïve guinea pigs were placed in the same cage and co-housed 
in this way for a total of 14 days. On 2, 4, 6, and 8 dpi, nasal washes of the three inoculated animals and three 
contact animals were collected and titrated. The area under the nasal wash curve between days 2 and 6 post 
inoculation (AUC2–6 dpi) was calculated from the virus titers of nasal wash of all guinea pig using GraphPad 
Prism 6 software as previously described27. All animals were euthanized at 14 dpi and sera were collected for 
seroconversion tests.
HI assay and antisera. HI assays were used to determine the antigenic cross-reactivity of EA SIV with 
prevailing human seasonal H1N1, human seasonal H3N2, and pandemic H1N1/2009 viruses. Positive human 
sera were collected from two 4-year-old children at 30 days after two immunizations with influenza bivalent 
vaccine comprising A/Victoria/361/2009 and A/California/07/2009 by Chinese National Influenza Center. 
HI antigens of A/Victoria/361/2009 (human seasonal H3N2), A/Tianjin-jinnan/15/2009 (human seasonal 
H1N1), A/California/07/09 (pandemic 2009 H1N1), and hyperimmune goat serum against human seasonal A/
Tianjin-jinnan/15/2009 were provided by Chinese National Influenza Center. Antisera against pdm/BJ09 or EA/
FJ04 were prepared from ferrets inoculated by 106 TCID50 of A/Beijing/7/2009 or A/Swine/Fujian/04/2007. HI 
tests were performed in accordance with WHO guidelines. All HI assays were performed in duplicates.
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Statistical analysis. Statistical analysis and graphical presentation were performed using the GraphPad 
Prism 6 software. Viral titers were calculated as medians with standard deviations. Statistical significance (P 
values) between the groups was compared using one-way analysis of variance (ANOVA) and Tukey’s multiple 
comparison tests.
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